Trial Profile
Prospective Biomarkers of Bone Metabolism in Hemophilia A
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Biomarker; Pharmacodynamics
- 10 Mar 2020 Status changed from recruiting to completed.
- 26 Sep 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2017.
- 26 Sep 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.